| Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma A Méjean, A Ravaud, S Thezenas, S Colas, JB Beauval, K Bensalah, ... New England Journal of Medicine 379 (5), 417-427, 2018 | 923 | 2018 |
| Personalized 3D printed model of kidney and tumor anatomy: a useful tool for patient education JC Bernhard, S Isotani, T Matsugasumi, V Duddalwar, AJ Hung, E Suer, ... World journal of urology 34, 337-345, 2016 | 354 | 2016 |
| Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery K Bensalah, AJ Pantuck, N Rioux-Leclercq, R Thuret, F Montorsi, ... European urology 57 (3), 466-473, 2010 | 332 | 2010 |
| Morbidity and clinical outcome of nephron-sparing surgery in relation to tumour size and indication JJ Patard, AJ Pantuck, M Crepel, JS Lam, L Bellec, B Albouy, D Lopes, ... European urology 52 (1), 148-154, 2007 | 314 | 2007 |
| Magnetic resonance imaging–transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens … E Baco, O Ukimura, E Rud, L Vlatkovic, A Svindland, M Aron, S Palmer, ... European urology 67 (4), 787-794, 2015 | 256 | 2015 |
| COVID‐19 and urology: a comprehensive review of the literature S Puliatti, A Eissa, R Eissa, M Amato, E Mazzone, P Dell’Oglio, ... BJU international 125 (6), E7-E14, 2020 | 232 | 2020 |
| MET is a potential target across all papillary renal cell carcinomas: result from a large molecular study of pRCC with CGH array and matching gene expression array L Albiges, J Guegan, A Le Formal, V Verkarre, N Rioux-Leclercq, ... Clinical Cancer Research 20 (13), 3411-3421, 2014 | 175 | 2014 |
| Comparison of 1800 robotic and open partial nephrectomies for renal tumors B Peyronnet, T Seisen, E Oger, C Vaessen, Y Grassano, T Benoit, ... Annals of surgical oncology 23, 4277-4283, 2016 | 161 | 2016 |
| Routinely performed multiparametric magnetic resonance imaging helps to differentiate common subtypes of renal tumours F Cornelis, E Tricaud, AS Lasserre, F Petitpierre, JC Bernhard, Y Le Bras, ... European radiology 24, 1068-1080, 2014 | 131 | 2014 |
| Predictive value of magnetic resonance imaging determined tumor contact length for extracapsular extension of prostate cancer E Baco, E Rud, L Vlatkovic, A Svindland, HB Eggesbø, AJ Hung, ... The Journal of urology 193 (2), 466-472, 2015 | 122 | 2015 |
| Neoadjuvant targeted molecular therapies in patients undergoing nephrectomy and inferior vena cava thrombectomy: is it useful? P Bigot, T Fardoun, JC Bernhard, E Xylinas, J Berger, M Rouprêt, ... World journal of urology 32, 109-114, 2014 | 112 | 2014 |
| Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population Y Neuzillet, X Tillou, R Mathieu, JA Long, M Gigante, P Paparel, ... European urology 60 (2), 366-373, 2011 | 105 | 2011 |
| Predictive factors for ipsilateral recurrence after nephron-sparing surgery in renal cell carcinoma JC Bernhard, AJ Pantuck, H Wallerand, M Crepel, JM Ferrière, L Bellec, ... European urology 57 (6), 1080-1086, 2010 | 105 | 2010 |
| Clinicopathological features and prognosis of synchronous bilateral renal cell carcinoma: an international multicentre experience T Klatte, H Wunderlich, JJ Patard, MD Kleid, JS Lam, K Junker, J Schubert, ... BJU international 100 (1), 21-25, 2007 | 105 | 2007 |
| Sunitinib stimulates expression of VEGFC by tumor cells and promotes lymphangiogenesis in clear cell renal cell carcinomas M Dufies, S Giuliano, D Ambrosetti, A Claren, PD Ndiaye, M Mastri, ... Cancer research 77 (5), 1212-1226, 2017 | 99 | 2017 |
| Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics C Jeldres, JJ Patard, U Capitanio, P Perrotte, N Suardi, M Crepel, ... Urology 73 (6), 1300-1305, 2009 | 96 | 2009 |
| Robotic unclamped “minimal-margin” partial nephrectomy: ongoing refinement of the anatomic zero-ischemia concept R Satkunasivam, S Tsai, S Syan, JC Bernhard, AL de Castro Abreu, ... European urology 68 (4), 705-712, 2015 | 87 | 2015 |
| Complete histologic remission after sunitinib neoadjuvant therapy in T3b renal cell carcinoma G Robert, G Gabbay, R Bram, H Wallerand, C Deminière, F Cornelis, ... European urology 55 (6), 1477-1480, 2009 | 86 | 2009 |
| Sunitinib alone or after nephrectomy for patients with metastatic renal cell carcinoma: is there still a role for cytoreductive nephrectomy? A Méjean, A Ravaud, S Thezenas, C Chevreau, K Bensalah, L Geoffrois, ... European Urology 80 (4), 417-424, 2021 | 85 | 2021 |
| Nivolumab, nivolumab–ipilimumab, and VEGFR-tyrosine kinase inhibitors as first-line treatment for metastatic clear-cell renal cell carcinoma (BIONIKK): a biomarker-driven, open … YA Vano, R Elaidi, M Bennamoun, C Chevreau, D Borchiellini, D Pannier, ... The Lancet Oncology 23 (5), 612-624, 2022 | 83 | 2022 |
ROBERT GrégoireCHU de Bordeaux, Université de Bordeaux, Bordeaux Pellegrin University hospitalVerified email at chu-bordeaux.fr
